Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis

International Journal of Cancer

Volumn 86, Issue 1, 2000, Pages 30-39

  Jadeski, Lorraine C ^a   Hum, Kathleen O ^a   Chakraborty, Chandan ^a   Lala, Peeyush K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; CELL CYCLE; CELL DIVISION; CELL MOVEMENT; ENZYME INHIBITORS; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; TUMOR CELLS, CULTURED;

EID: 0011031944     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000401)86:1<30::AID-IJC5>3.0.CO;2-I     Document Type: Article

References (30)

1. BAGULEY, B.C., CALVELEY, S.B., CROWE, K.K., FRAY, L.M. and O'ROUKE, S.A., Comparison of the effects of flavone acetic acid, fostriecin, homoharrgtone and tumour necrosis factor α on colon 38 tumours in mice. Europ. J. Cancer Clin. Oncol., 25, 263-269 (1989).
2. BRODT, R., PARHAR, R., SANKAR, P. and LALA, P.K., Studies on clonal heterogeneity in two spontaneously metastasizing mammary carcinomas of recent origin. Int. J. Cancer, 35, 265-273 (1985).
3. COBBS, C.S., BRENMAN, J.E., ALDAPE, K.D., BREDT, D.S. and ISRAEL, M.A., Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res., 55, 727-730 (1995).
4. DAVISON, W. and WOOF, C., Comparison of different forms of cadmium as reducing agents for the batch determination of nitrate. Analyst, 103, 403-406 (1978).
5. DUEÑAS-GONZALES, A., ISALES, C.M., DEL MAR ABAD-HERNANDEZ, M., GONZALEZ-SARMIENTO, R., SANGUEZA, O. and RODRIGUEZ-COMMES, J., Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mod. Pathol., 10, 645-649 (1997).
6. EDWARDS, P., CENDAN, J.C., TOPPING, D.B., MOLDAWER, L.L., MACKAY, S., COPELAND, E.M. and LIND, D.S., Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J. Surg. Res., 63, 49-52 (1996).
7. FUJIMOTO, H., ANDO, Y., YAMASHITA, T., TERAZAKI, H., TANAKA, Y., SASAKI, J., MATSUMOTO, M., SUGA, M. and ANDO, M., Nitric oxide synthase activity in human lung cancer. Jpn. J. Cancer Res., 88, 1190-1198 (1997).
8. GALLO, O., MASINI, E., MORBIDELLI, L., FRANCHI, A., FINI-STORCHI, I., VERGARI, W.A. and ZICHE, M., Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. nat. Cancer Inst., 90, 587-596 (1998).
9. 15N]nitrate in biological fluids. Anal. Biochem., 126, 131-138 (1982).
10. G-nitro-L-arginine methyl ester (L-NAME) inhibits tumour-induced angiogenesis in mammary tumours. Amer. J Pathol., 155, 1381-1390 (1999).
11. JENKINS, D.C., CHARLES, I.G., THOMSEN, L.L., MOSS, D.W., HOLMES, L.S., BAYLIS, S.A., RHODES, P., WESTMORE, K., EMSON, P.C. and MONCADA, S., Roles of nitric oxide in tumor growth. Proc. nat. Acad. Sci. (Wash.), 92, 4392-4396 (1995).
12. KENNOVIN, G.D., HIRST, D.G., STRATFORD, M.R.L. and FLITNEY, F.W., Inducible nitric oxide synthase is expressed in tumor-associated vasculature: inhibition retards tumor in vivo. In: S. Moncada, M. Feelisch, R. Busse and E.A. Higgs (eds.), Biology of nitric oxide. Part 4, Enzymology, biochemistry, and immunology, pp. 473-479, Portland Press, London (1994).
13. KLOTZ, T., BLOCH, W., VOLBERG, C., ENGELMANN, U. and ADDICKS, K., Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer, 82, 1897-1903 (1998).
14. KNOWLES, R.G. and MONCADA, S., Nitric oxide synthases in mammals. Biochem. J., 298, 249-258 (1994).
15. LALA, P.K., AL-MUTTER, N. and ORUCEVIC, A., Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HeJ mice. Int. J. Cancer, 73, 371-380 (1997).
16. LALA, P.K. and ORUCEVIC, A., Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev., 17, 91-106 (1998).
17. LALA, P.K. and PARHAR, R.S., Eradication of spontaneous and experimental adenocarcinoma metastases with chronic indomethacin and intermittent IL-2 therapy. Int. J. Cancer, 54, 677-684 (1993).
18. LALA, P.K., PARHAR, R.S. and SINGH, P., Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumour-bearing mice and prevents tumour metastasis. Cell. Immunol., 99, 108-118 (1986).
19. LEHR, H.-A., MANKOFF, D.A., CORWIN, D., SANTEUSANIO, G. and GOWN, A.M., Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J. Histochem. Cytochem., 45, 1559-1565 (1997).
20. MONCADA, S. and HIGGS, A., The L-arginine-nitric oxide pathway. N. Engl. J. Med., 329, 2002-2012 (1993).
21. MURRELL, G.A.A., JANG, D. and WILLIAMS, R.J., Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. Biophys. Res. Comm., 206, 15-21 (1995).
22. ORUCEVIC, A., BECHBERGER, J., GREEN, A.M., SHAPIRO, R.A., BILLIAR, T.R. and LALA, P.K., Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int. J. Cancer, 81, 889-896 (1999).
23. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on IL-2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice. Cancer Immunol. Immunother., 42, 38-46 (1996a).
24. G-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin-2-induced capillary leakage and reduces tumor growth in adenocarcinoma-bearing mice. Brit. J. Cancer, 73, 189-196 (1996b).
25. TAMURA, T., TAKANISHI, T., KIMURA, Y., SASAKI, D., NORIMATSU, H., TAKAHASHI, D. and TAKIGAWA, M., Nitric oxide mediates interleukin-2-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes. A possible mechanism of pathological neovascularization in arthritis. Endocrinology, 137, 3729-3737 (1996).
26. THOMSEN, L.L., LAWTON, F.G., KNOWLES, R.G., BEESLEY, J.E., RIVEROSMORENO, V. and MONCADA, S., Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54, 1352-1354 (1994).
27. THOMSEN, L.L. and MILES, D.W., Role of nitric oxide in tumor progression: lessons from human tumors. Cancer Metastasis Rev., 17, 107-118 (1998).
28. THOMSEN, L.L., MILES, D.W., HAPPERFIELD, L., BOBROW, L.G., KNOWLES, R.G. and MONCADA, S., Nitric oxide synthase activity in human breast cancer. Brit. J. Cancer, 72, 41-44 (1995).
29. ZICHE, M., MORBIDELLI, L., CHOUDHURI, R., ZHANG, H.T., DONNINI, S., GRANGER, H.J. and BICKNELL, R., Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor-induced angiogenesis. J. clin. Invest., 99, 2625-2634 (1997).
30. ZICHE, M., MORBIDELLI, L., MASINI, E., AMERINI, S., GRANGER, H.J., MAGGI, C.A., GEPPETH, P. and LEDDA, F., Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. clin. Invest., 94, 2036-2044 (1994).